iQure Pharma
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$7.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iQure Pharma is a biotechnology company that develops innovative therapeutics for central nervous system disorders by restoring glutamate homeostasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iQure Pharma Comparables
Compare iQure Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mentara Bio Inc. | 86% | |
| GliaPharm SA | 80% | |
| Astrocyte Pharmaceuticals Inc. | 75% |
iQure Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Series B | Jan 7, 2025 | ||||
| Series A | Nov 28, 2023 | ||||
| Series A | Oct 23, 2023 | ||||
| Series A | Sep 1, 2022 |
Key People
Founding team and executive leadership
iQure Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKG Capital | Series A, Series B |
| Ventura BioMed Investors | Series A |
| Keiretsu Forum Mid-Atlantic | Series A |
| i&i Prague | Series B |
| Mass Medical Angels | Series A |
| Ventura BioMedical | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 37% MoM.
- Jul 24, 2026
Monthly visitors grew 288% MoM, reaching 757.
iQure Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iQure Pharma's valuation, stock price, and market status.
Is iQure Pharma a public or private company?
iQure Pharma is a private company.
What is the current stock price of iQure Pharma?
iQure Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is iQure Pharma worth (valuation)?
Valuation information for iQure Pharma is not publicly available.
Can I buy iQure Pharma stock?
iQure Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was iQure Pharma's last funding round?
iQure Pharma's most recent funding round was Seed Round on June 3, 2026.
Who are the main investors in iQure Pharma?
Key investors in iQure Pharma include OKG Capital, Ventura BioMed Investors.
Will iQure Pharma IPO soon?
No public IPO plans have been announced for iQure Pharma.
How can I track iQure Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iQure Pharma's secondary market activity and sign up for updates.